It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
5-Aminolevulinic acid (5-ALA) is useful as a photodynamic agent, but its use commonly leads to hypotension. Although avoiding a mean arterial pressure (MAP) < 60 mmHg is important, the incidence of MAP < 60 mmHg when using 5-ALA is unclear. Therefore, we conducted a retrospective study to assess the incidence of post-induction hypotension and identified risk factors of this phenomenon.
Methods
One-hundred and seventy-two consecutive patients who underwent transurethral resection of the bladder tumor or craniotomy with the use of 5-ALA were enrolled. The primary outcome was the incidence of post-induction hypotension, defined as MAP < 60 mmHg during the first 1 h after anesthesia induction. We divided participants into the normal blood pressure group (group N) and the hypotension group (group L).
Results
The incidence of post-induction hypotension was 70% (group L = 121, group N = 51). Multivariate analysis revealed that female sex was an independent factor of post-induction hypotension (odds ratio [OR] 3.95; 95% confidence interval [CI] 1.21–12.97; p = 0.02). Systolic blood pressure < 100 mmHg before anesthesia induction and general anesthesia were also identified as significant independent factors (OR 13.30; 95% CI 1.17–151.0; p = 0.04 and OR 25.84; 95% CI 9.80–68.49; p < 0.001, respectively).
Conclusions
The incidence of post-induction hypotension was 70% in patients using 5-ALA. Female sex, systolic blood pressure < 100 mmHg before anesthesia induction, and general anesthesia might be independent factors of post-induction hypotension when using 5-ALA.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan
2 Kochi Medical School, Department of Urology, Kochi, Japan (GRID:grid.278276.e) (ISNI:0000 0001 0659 9825)
3 Kochi Medical School Hospital, Medical safety management center, Kochi, Japan (GRID:grid.415887.7) (ISNI:0000 0004 1769 1768)
4 Kochi Medical School, Department of Neurosurgery, Kochi, Japan (GRID:grid.415887.7)
5 Kochi Medical School, Department of Neurosurgery, Kochi, Japan (GRID:grid.278276.e)
6 Kochi Medical School, Center of Medical Information Science, Kochi, Japan (GRID:grid.278276.e) (ISNI:0000 0001 0659 9825)
7 Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan (GRID:grid.278276.e)